San Diego, CA, United States of America

Steven Spencer Clareen

USPTO Granted Patents = 7 



Average Co-Inventor Count = 8.2

ph-index = 7

Forward Citations = 185(Granted Patents)


Location History:

  • San Diego, CA (US) (2009 - 2013)
  • West Chester, PA (US) (2015 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovator Behind Aminopurine Compounds: Steven Spencer Clareen

Introduction

Steven Spencer Clareen is a distinguished inventor based in San Diego, California. With a notable portfolio of seven patents, Clareen has significantly contributed to the field of pharmaceutical sciences, particularly through his innovative work on aminopurines.

Latest Patents

Clareen's latest patents focus on "Haloaryl Substituted Aminopurines, Compositions Thereof, and Methods of Treatment Therewith." These patents present Aminopurine Compounds with a unique structure, which shows promise for new therapeutic methods in treating various conditions. His research underlines the potential of these compounds in advancing medicinal chemistry.

Career Highlights

Throughout his career, Steven Clareen has been associated with renowned companies in the pharmaceutical industry. He has worked for companies such as Signal Pharmaceuticals, Inc. and Pharmacopeia Drug Discovery, Inc., where he has honed his expertise in drug discovery and development. His contributions have had a lasting impact on the pharmaceutical sector, showcasing his innovative approach to solving complex healthcare problems.

Collaborations

In his professional journey, Clareen has collaborated with notable individuals like Maria Mercedes Delgado Mederos and Ronald J. Albers. These partnerships have enriched his research and enabled the intersection of different areas of expertise, contributing to the successful innovation of new pharmaceutical compounds.

Conclusion

Steven Spencer Clareen stands out as a prominent figure in the realm of pharmaceutical inventions. His innovative research on aminopurines and collaborations with other experts underscore his commitment to advancing medical treatments. As a patent holder, Clareen continues to inspire the future of drug discovery and the pursuit of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…